Testing effectiveness (Phase 2)Study completedNCT00091702
What this trial is testing
Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
Who this might be right for
HIV InfectionsInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 300